Physician profile
Sarah M Evans
NPI 1558474510
$503.68
in general payments reported to CMS, 2019-2025
9 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.76 · 2022: $45.23 · 2023: $234 · 2024: $3.20 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429 · Travel and Lodging: $9.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.95 |
| Travel and Lodging | $9.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $198.08 | 2022-2023 | Phasix Mesh |
| Advanced Oxygen Therapy INC. | $71.20 | 2025 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $50.67 | 2021-2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $43.66 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Madrigal Pharmaceuticals | $37.21 | 2025 | Rezdiffra |
| Novo Nordisk INC | $34.39 | 2025 | Wegovy |
| Baxter Healthcare | $27.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.72 | 2025 | Entyvio |
| Musculoskeletal Transplant Foundation INC. | $12.94 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.